Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

TransCon CNP, a Sustained-Release C-Type Natriuretic Peptide Prodrug, a Potentially Safe and Efficacious New Therapeutic Modality for the Treatment of Comorbidities Associated with Fibroblast Growth Factor Receptor 3-Related Skeletal Dysplasias.

Breinholt VM, Rasmussen CE, Mygind PH, Kjelgaard-Hansen M, Faltinger F, Bernhard A, Zettler J, Hersel U.

J Pharmacol Exp Ther. 2019 Sep;370(3):459-471. doi: 10.1124/jpet.119.258251. Epub 2019 Jun 24.

PMID:
31235532
2.

Tailor made pharmacokinetics of peptides by transient PEGylation.

Hersel U, Kreuzer M, Rau H, Vetter D, Wegge T.

Adv Exp Med Biol. 2009;611:277-8. No abstract available.

PMID:
19400191
3.

Photoswitched cell adhesion on surfaces with RGD peptides.

Auernheimer J, Dahmen C, Hersel U, Bausch A, Kessler H.

J Am Chem Soc. 2005 Nov 23;127(46):16107-10.

PMID:
16287297
4.

Mediating specific cell adhesion to low-adhesive diblock copolymers by instant modification with cyclic RGD peptides.

Lieb E, Hacker M, Tessmar J, Kunz-Schughart LA, Fiedler J, Dahmen C, Hersel U, Kessler H, Schulz MB, Göpferich A.

Biomaterials. 2005 May;26(15):2333-41.

PMID:
15585236
5.

Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and octreotide analogs.

Poethko T, Schottelius M, Thumshirn G, Hersel U, Herz M, Henriksen G, Kessler H, Schwaiger M, Wester HJ.

J Nucl Med. 2004 May;45(5):892-902.

6.

RGD modified polymers: biomaterials for stimulated cell adhesion and beyond.

Hersel U, Dahmen C, Kessler H.

Biomaterials. 2003 Nov;24(24):4385-415. Review.

PMID:
12922151
7.

Supplemental Content

Loading ...
Support Center